Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II Trial of Oral CAI in Refractory Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
NCT00019461Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- Apr 1998
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of carboxyamidotriazole in ovarian epithelial cancer, fallopian tube cancer (PFTC), primary peritoneal cancer (PPC), sponsored by National Cancer Institute. Started Apr 1998; status: completed.
02
Drugs
carboxyamidotriazole
03
Conditions
ovarian epithelial cancerfallopian tube cancer (PFTC)primary peritoneal cancer (PPC)
Beyond the preview
Go deeper on NCT00019461.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00019461.